These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19847158)

  • 1. Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions.
    Ai D; Shyy JY; Zhu Y
    Kidney Int; 2010 Jan; 77(2):88-92. PubMed ID: 19847158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
    Zhang H; Wang T; Zhang K; Liu Y; Huang F; Zhu X; Liu Y; Wang MH; Tang W; Wang J; Huang H
    Crit Care Med; 2014 May; 42(5):e345-54. PubMed ID: 24448199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.
    Ai D; Fu Y; Guo D; Tanaka H; Wang N; Tang C; Hammock BD; Shyy JY; Zhu Y
    Proc Natl Acad Sci U S A; 2007 May; 104(21):9018-23. PubMed ID: 17495027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
    Jung O; Brandes RP; Kim IH; Schweda F; Schmidt R; Hammock BD; Busse R; Fleming I
    Hypertension; 2005 Apr; 45(4):759-65. PubMed ID: 15699457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy.
    Ai D; Pang W; Li N; Xu M; Jones PD; Yang J; Zhang Y; Chiamvimonvat N; Shyy JY; Hammock BD; Zhu Y
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):564-9. PubMed ID: 19126686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
    Zhao X; Yamamoto T; Newman JW; Kim IH; Watanabe T; Hammock BD; Stewart J; Pollock JS; Pollock DM; Imig JD
    J Am Soc Nephrol; 2004 May; 15(5):1244-53. PubMed ID: 15100364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.
    Sporková A; Jíchová S; Husková Z; Kopkan L; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Cervenka L
    Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):1003-13. PubMed ID: 25224811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.
    Imig JD; Zhao X; Capdevila JH; Morisseau C; Hammock BD
    Hypertension; 2002 Feb; 39(2 Pt 2):690-4. PubMed ID: 11882632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α-linolenic acid-induced inhibition of soluble epoxide hydrolase.
    Caligiuri SP; Aukema HM; Ravandi A; Guzman R; Dibrov E; Pierce GN
    Hypertension; 2014 Jul; 64(1):53-9. PubMed ID: 24777981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation.
    Sinal CJ; Miyata M; Tohkin M; Nagata K; Bend JR; Gonzalez FJ
    J Biol Chem; 2000 Dec; 275(51):40504-10. PubMed ID: 11001943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
    Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular localization of soluble epoxide hydrolase in the human kidney.
    Yu Z; Davis BB; Morisseau C; Hammock BD; Olson JL; Kroetz DL; Weiss RH
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F720-6. PubMed ID: 14665429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.
    Ulu A; Harris TR; Morisseau C; Miyabe C; Inoue H; Schuster G; Dong H; Iosif AM; Liu JY; Weiss RH; Chiamvimonvat N; Imig JD; Hammock BD
    J Cardiovasc Pharmacol; 2013 Sep; 62(3):285-97. PubMed ID: 23676336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
    Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
    Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
    Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
    Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
    Kujal P; Čertíková Chábová V; Škaroupková P; Husková Z; Vernerová Z; Kramer HJ; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Kitada K; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Červenka L
    Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):227-37. PubMed ID: 24471737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epoxide hydrolase: A potential target for metabolic diseases.
    He J; Wang C; Zhu Y; Ai D
    J Diabetes; 2016 May; 8(3):305-13. PubMed ID: 26621325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia.
    Zhang LN; Vincelette J; Cheng Y; Mehra U; Chen D; Anandan SK; Gless R; Webb HK; Wang YX
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1265-70. PubMed ID: 19667112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension.
    Zhang LN; Vincelette J; Chen D; Gless RD; Anandan SK; Rubanyi GM; Webb HK; MacIntyre DE; Wang YX
    Eur J Pharmacol; 2011 Mar; 654(1):68-74. PubMed ID: 21187082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetramethylpyrazine suppresses angiotensin II-induced soluble epoxide hydrolase expression in coronary endothelium via anti-ER stress mechanism.
    Mak SK; Yu CM; Sun WT; He GW; Liu XC; Yang Q
    Toxicol Appl Pharmacol; 2017 Dec; 336():84-93. PubMed ID: 29066182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.